Summary: Maclean’s reports on the progress of MAPS’ ongoing clinical trial of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. MAPS Canada Chairman Mark Haden is interviewed about the importance of expanding psychedelic research and education, and MDMA-assisted psychotherapy study participant and U.S. veteran Virgil Huston speaks about the benefits of psychedelic therapy in comparison to traditional PTSD treatments. “This isn’t just about the drug; it’s about the psychological process, and building trust with a wonderful therapist,” he says. “I still think about the wars, but they don’t keep me awake at night all the time—which is, frankly, incredible.”
Originally appearing here.